THE SOLUTION

Marginum tissue monitoring solution assists in precise detection of tumour without additional invasive steps.

CHALLENGE

Surgeons regularly face problems during cancer surgery:

Marginum cancer screening icon

Tumour cells
left undetected 

Marginum cutting icon

Healthy tissues
unnecessarily resected

Marginum brains icon

Operative workflows
are complex

SOLUTION

Marginum HIVEN® enables unforeseen manual control for detection of tissues:

marginum product img
marginum product img

Device: HIVEN® Aspirate Tissue Detector, risk Class IIb (EU MDR Certified)
UDI-DI: 06429810994004
Manufacturer: Marginum Ltd, Åkerlundinkatu 8, 33100 Tampere Finland

Intended use: HIVEN® device is intended for tissue fluorescence detection during fluorescence-guided surgical operations for suspected high-grade gliomas in which 5-aminolevulinic acid (5-ALA) is used. The device is used for detecting fluorescence of flowing tissues within a transparent tube and providing auditory feedback of tissue fluorescence for neurosurgeons. There is no patient contact intended with this device.

The patient benefit from using the device is increased detection of fluorescence during surgery. The detection of fluorescence has been shown to lead to more complete resection of tumour and improved progression-free survival.

Refer to the instruction manual. Training is mandatory for first-time users.

magnifying glass and tissue

Precise detection
of tissue fluorescence

Human body

Minimal damage
to healthy tissues 

checkmark

Simplified workflow
at all times

QUALITY

Marginum Ltd is a responsible medical device manufacturer. 

 

All Marginum products and the quality management system comply with the applicable requirements of the Regulation (EU MDR) 2017/745. Our Quality Management System is also certified according to the standards ISO 13485:2016 and EN ISO 13485:2016.

LEADING HEALTHCARE INSTITUTIONS TRUSTING MARGINUM®

OUR PRODUCT

Effortless, near real-time operating MARGINUM® device monitors the surgical suction fluids’ content and analyses the intensity of tissue fluorescence.

The surgeon is informed, if any traces of fluorescent tissue are present in the resected tissue with truly objective and precise feedback. The device platform utilises FLUOSIGHT® software suite for accurate measurement.

CONTACT US

UNOBTRUSIVE

Effortless to use

Intuitive

Hardware-fixed interface with audio feedback from analysis

ECONOMIC

Design utilises streamlined materials & production is planned with minimal carbon footprint

STAND-ALONE

Integrates seamlessly to existing workflow

ROBUST

Technically failsafe

RELIABLE

Highly sensitive & specific analysis

SMART

Automated operation